Replimune Group (REPL)
(Delayed Data from NSDQ)
$9.86 USD
+0.13 (1.34%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $9.85 -0.01 (-0.10%) 7:44 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Income Statements
Fiscal Year end for Replimune Group, Inc falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 235 | 177 | 118 | 80 | 56 |
Income After Depreciation & Amortization | -235 | -177 | -118 | -80 | -56 |
Non-Operating Income | 26 | 7 | 3 | 2 | 5 |
Interest Expense | 7 | 4 | 2 | 3 | 2 |
Pretax Income | -215 | -174 | -118 | -81 | -53 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -216 | -174 | -118 | -81 | -53 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -216 | -174 | -118 | -81 | -53 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -244 | -180 | -114 | -77 | -57 |
Depreciation & Amortization (Cash Flow) | -10 | -3 | 4 | 3 | 0 |
Income After Depreciation & Amortization | -235 | -177 | -118 | -80 | -56 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | 66.57 | 58.21 | 52.21 | 46.25 | 34.26 |
Diluted EPS Before Non-Recurring Items | -3.24 | -2.99 | -2.26 | -1.75 | -1.54 |
Diluted Net EPS (GAAP) | -3.24 | -2.99 | -2.26 | -1.75 | -1.54 |
Fiscal Year end for Replimune Group, Inc falls in the month of March .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 57.37 | 58.76 | 56.54 | 63.83 | 55.65 |
Income After SG&A, R&D, and Dept/Amort Expenses | -57.37 | -58.76 | -56.54 | -63.83 | -55.65 |
Non-Operating Income | 5.56 | 5.57 | 7.45 | 5.08 | 7.95 |
Interest Expense | 1.96 | 1.95 | 1.55 | 1.50 | 1.66 |
Pretax Income | -53.77 | -55.14 | -50.65 | -60.25 | -49.35 |
Income Taxes | NA | -0.07 | 0.47 | -0.20 | 0.20 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -53.77 | -55.08 | -51.12 | -60.04 | -49.56 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -53.77 | -55.08 | -51.12 | -60.04 | -49.56 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 69.19 | 67.17 | 66.65 | 66.58 | 66.37 |
Diluted EPS Before Non-Recurring Items | -0.78 | -0.82 | -0.77 | -0.90 | -0.75 |
Diluted Net EPS (GAAP) | -0.78 | -0.82 | -0.77 | -0.90 | -0.75 |